Evidence map›Paper›PMID 22871916›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study.

Kejia Cai, Ravi Pr Nanga, Lisa Lamprou, Claudia Schinstine, Mark Elliott, Hari Hariharan, Ravinder Reddy, C Neill Epperson

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01954966 phase4completednot on this map

Multimodal Imaging of Progesterone/Neurosteroid Effects in Nicotine Addiction

TypeinterventionalSponsorUniversity of PennsylvaniaRan2010 to 2021Enrolled81ConditionsNicotine Dependence, Nicotine WithdrawalArmsProgesterone, Placebo
NCT03220776 phase2completednot on this mapstarted 2017, after this paper: background citation

Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics

TypeinterventionalSponsorMedical University of South CarolinaRan2017 to 2022Enrolled54ConditionsAlcohol Use Disorder, Bipolar DisorderArmsN-Acetylcysteine, Gabapentin, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Protective Effects ofFood science & nutrition · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Cenobamate reduces epileptiform activity in theFrontiers in neuroscience · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kejia CaiDepartment of Radiology, Center for Magnetic Resonance and Optical Imaging-CMROI, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Ravi Pr Nanga
Lisa Lamprou
Claudia Schinstine
Mark Elliott
Hari Hariharan
Ravinder Reddy
C Neill Epperson
University of Pennsylvania · US

Funding

Training and DisseminationP41EB015893 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI REDDY, RAVINDER · 2012 to 2019
$11.3M
Prepubertal Stress, Windows of Risk & Sex Bias for Affective DisturbanceP50MH099910 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI EPPERSON, C. NEILL · 2012 to 2017
$6.5M
Sex, GABA and Nicotine: A 1H-MRS StudyR01DA018359 · NIDA · YALE UNIVERSITY · PI EPPERSON, C. NEILL · 2006 to 2010
$1.4M
Neuroendocrine Contribution to Behavior & Cognition in the Female LifespanK24DA030301 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI EPPERSON, C. NEILL · 2010 to 2014
$954k
In Vivo Cerebral Glutamate Mapping in AddictionR21DA032256 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI REDDY, RAVINDER · 2011 to 2012
$400k
NIBIB NIH HHS P41 EB015893NIBIB NIH HHS P41-EB015893NIDA NIH HHS K24 DA030301NIDA NIH HHS R01 DA018359NIDA NIH HHS R21 DA032256NIDA NIH HHS R21-DA032256NIMH NIH HHS P50 MH099910
6 · The paper itself

Abstract

Gamma-aminobutyric acid (GABA) and glutamate are implicated in numerous neuropsychiatric and substance abuse conditions, but their spectral overlap with other resonances makes them a challenge to quantify in humans. Gabapentin, marketed for the treatment of seizures and neuropathic pain, has been shown to increase in vivo GABA concentration in the brain of both rodents and humans. Gabapentin effects on glutamate are not known. We conducted a gabapentin (900 mg) challenge in healthy human subjects to confirm and explore its effects on GABA and glutamate concentrations, respectively, and to test the ability of single voxel localized proton magnetic resonance spectroscopy (¹H-MRS) to reliably measure GABA and glutamate in the visual cortex at the ultra-high magnetic field of 7 Tesla. Reproducibility of GABA and glutamate measurements was determined in a comparison group without drug twice within day and 2 weeks apart. Although GABA concentration changes were small both within day (average 5.6%) and between day (average 4.8%), gabapentin administration was associated with an average increase in GABA concentration of 55.7% (6.9-91.0%). Importantly, drug-induced change in GABA levels was inversely correlated to the individual's baseline GABA level (R²=0.72). Mean glutamate concentrations did not change significantly with or without drug administration. In conclusion, localized ¹H-MRS at 7 Tesla can be successfully applied to the measurement of GABA concentration and is sensitive to acute drug-induced changes in cortical GABA. Whether baseline GABA concentrations predict clinical efficacy of gabapentin is an area worthy of exploration.

Indexed as

Magnetic Resonance SpectroscopyAdministration, OralAdultAminesAnticonvulsantsBrainCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidGlutamic AcidHumansMaleProtonsYoung AdultAminesAnticonvulsantsCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidGlutamic AcidProtons

Identifiers

PMID22871916
PMCPMC3499716
OpenAlexW2039450042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.